Liver metastasis
Liver Metastasis
Liver metastasis, also known as hepatic metastasis, refers to the spread of cancer cells from their original (primary) site to the liver. This is a common occurrence in the progression of various types of cancer, including colorectal cancer, breast cancer, lung cancer, and pancreatic cancer.
Overview[edit | edit source]
Liver metastasis is not the same as liver cancer, which starts in the liver. Instead, it is a secondary cancer that has spread (metastasized) from another part of the body. The liver is a common site for metastasis due to its rich, dual blood supply and the numerous biological factors that promote the survival and growth of metastatic cells.
Pathophysiology[edit | edit source]
The process of metastasis involves several steps, collectively known as the metastatic cascade. Cancer cells detach from the primary tumor, invade the surrounding tissue, enter the bloodstream or lymphatic system, and travel to the liver. Once there, they extravasate into the liver tissue, survive, proliferate, and form a secondary tumor.
Clinical Presentation[edit | edit source]
Symptoms of liver metastasis can vary widely, depending on the size and location of the metastatic lesions. Common symptoms include jaundice, hepatomegaly (enlarged liver), ascites (fluid accumulation in the abdomen), and pain in the upper right abdomen.
Diagnosis[edit | edit source]
Diagnosis of liver metastasis typically involves imaging studies such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and ultrasound. Biopsy may also be performed to confirm the diagnosis.
Treatment[edit | edit source]
Treatment options for liver metastasis depend on several factors, including the type and stage of the primary cancer, the size and number of metastatic lesions in the liver, and the patient's overall health. Treatment may involve surgery, radiotherapy, chemotherapy, targeted therapy, or a combination of these.
Prognosis[edit | edit source]
The prognosis for patients with liver metastasis is generally poor, with a median survival time of less than one year. However, survival can vary widely depending on the type and stage of the primary cancer, the extent of the liver involvement, and the treatments used.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD